Minocycline Hydrochloride Patent Expiration

Minocycline Hydrochloride was first introduced by Triax Pharmaceuticals Llc in its drug Minocin on Approved Prior to Jan 1, 1982. Other drugs containing Minocycline Hydrochloride are Zilxi, Minocycline Hydrochloride, Solodyn, Ximino, Arestin, Minolira, Amzeeq. 32 different companies have introduced drugs containing Minocycline Hydrochloride.


Minocycline Hydrochloride Patents

Given below is the list of patents protecting Minocycline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Amzeeq US10086080 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US10137200 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Amzeeq US10213512 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US10265404 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Amzeeq US10398641 Compositions and methods for treating rosacea and acne Sep 08, 2037 Journey
Amzeeq US10517882 Method for healing of an infected acne lesion without scarring Oct 01, 2030 Journey
Amzeeq US10821187 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Amzeeq US10849847 Compositions and methods for treating rosacea and acne Sep 08, 2037 Journey
Amzeeq US8865139 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Amzeeq US8992896 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US9675700 Topical tetracycline compositions Oct 01, 2030 Journey
Arestin US6682348 Dispensing apparatus and cartridge Mar 29, 2022

(Expired)

Orapharma
Arestin US7699609 Dispensing apparatus and cartridge with deformable tip Mar 29, 2022

(Expired)

Orapharma
Minocin US11944634 Tetracycline compositions Oct 16, 2032 Rempex
Minocin US9084802 Tetracycline compositions May 12, 2031 Rempex
Minocin US9278105 Tetracycline compositions May 12, 2031 Rempex
Minolira US11103517 Pharmaceutical compositions for minocycline Apr 07, 2036 Epi Hlth
Solodyn US5908838 Method for the treatment of acne Feb 19, 2018

(Expired)

Bausch
Solodyn US7541347 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Bausch
Solodyn US7544373 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Bausch
Solodyn US7790705 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025 Bausch
Solodyn US7919483 Method for the treatment of acne Mar 07, 2027 Bausch
Solodyn US8252776 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025 Bausch
Solodyn US8268804 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025 Bausch
Solodyn US8722650 Extended-release minocycline dosage forms Jun 24, 2025 Bausch
Solodyn US9192615 Method for the treatment of acne and certain dosage forms thereof Nov 17, 2031 Bausch
Ximino US5908838 Method for the treatment of acne Feb 19, 2018

(Expired)

Journey
Ximino US7541347 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Journey
Ximino US7544373 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Journey
Ximino US7790705 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025 Journey
Ximino US7919483 Method for the treatment of acne Mar 07, 2027 Journey
Ximino US8252776 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025 Journey
Ximino US8268804 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025 Journey
Zilxi US10213512 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10265404 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Zilxi US10322186 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10946101 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Zilxi US8865139 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Zilxi US8992896 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US9675700 Topical tetracycline compositions Oct 01, 2030 Journey


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Minocycline Hydrochloride Generics

Several generic applications have been filed for Minocycline Hydrochloride. The first generic version for Minocycline Hydrochloride was by Lederle Laboratories Div American Cyanamid Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Jun 16, 2023.

Given below is the list of companies who have filed for Minocycline Hydrochloride generic.


1. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Prescription ORAL AB Dec 30, 1991


2. ALVOGEN

Alvogen Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. All of these versions come by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Jul 31, 1990
EQ 50MG BASE capsule Discontinued ORAL N/A Aug 14, 1990
EQ 75MG BASE capsule Discontinued ORAL N/A Sep 15, 1999


3. BEXIMCO PHARMS USA

Beximco Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB May 27, 2022
EQ 50MG BASE tablet Prescription ORAL AB May 27, 2022
EQ 75MG BASE tablet Prescription ORAL AB May 27, 2022


4. LEDERLE

Lederle Laboratories Div American Cyanamid Co has filed for 1 generic for Minocycline Hydrochloride. This eq 100mg base/vial version comes by the name MINOCIN. Given below are the details of the strengths of this generic introduced by Lederle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


5. IMPAX LABS INC

Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG BASE tablet, extended release Discontinued ORAL N/A Feb 3, 2009
EQ 135MG BASE tablet, extended release Discontinued ORAL N/A Feb 3, 2009
EQ 90MG BASE tablet, extended release Discontinued ORAL N/A Feb 3, 2009


6. NEXUS PHARMS

Nexus Pharmaceuticals Inc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Nexus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL injectable Prescription INJECTION AP Jul 22, 2022


7. RISING

Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 80MG BASE tablet, extended release Discontinued ORAL N/A Aug 22, 2014
EQ 105MG BASE tablet, extended release Discontinued ORAL N/A Aug 22, 2014
EQ 115MG BASE tablet, extended release Discontinued ORAL N/A Jul 30, 2019
EQ 65MG BASE tablet, extended release Discontinued ORAL N/A Jul 30, 2019
EQ 55MG BASE tablet, extended release Discontinued ORAL N/A Aug 21, 2019


8. BARR LABS INC

Barr Laboratories Inc has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 90MG BASE tablet, extended release Discontinued ORAL N/A Mar 17, 2009
EQ 45MG BASE tablet, extended release Discontinued ORAL N/A Mar 17, 2009
EQ 135MG BASE tablet, extended release Discontinued ORAL N/A Mar 17, 2009
EQ 65MG BASE tablet, extended release Discontinued ORAL N/A May 18, 2012
EQ 115MG BASE tablet, extended release Discontinued ORAL N/A May 18, 2012
EQ 105MG BASE tablet, extended release Discontinued ORAL N/A Apr 26, 2017
EQ 80MG BASE tablet, extended release Discontinued ORAL N/A Apr 26, 2017


9. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG BASE tablet, extended release Discontinued ORAL N/A Jul 20, 2010
EQ 90MG BASE tablet, extended release Discontinued ORAL N/A Jul 20, 2010
EQ 45MG BASE tablet, extended release Discontinued ORAL N/A Jul 20, 2010


10. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE tablet Prescription ORAL AB Dec 26, 2007
EQ 100MG BASE tablet Prescription ORAL AB Dec 26, 2007
EQ 75MG BASE tablet Prescription ORAL AB Dec 26, 2007


11. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG BASE tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 135MG BASE tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 105MG BASE tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 90MG BASE tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 80MG BASE tablet, extended release Discontinued ORAL N/A Sep 25, 2014
EQ 115MG BASE tablet, extended release Discontinued ORAL N/A Dec 3, 2019
EQ 65MG BASE tablet, extended release Discontinued ORAL N/A Dec 3, 2019


12. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 11 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG BASE tablet, extended release Prescription ORAL AB Nov 19, 2012
EQ 90MG BASE tablet, extended release Prescription ORAL AB Nov 19, 2012
EQ 45MG BASE tablet, extended release Prescription ORAL AB Nov 19, 2012
EQ 80MG BASE tablet, extended release Prescription ORAL AB Jun 13, 2016
EQ 105MG BASE tablet, extended release Prescription ORAL AB Jun 13, 2016
EQ 65MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2018
EQ 115MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2018
EQ 55MG BASE tablet, extended release Prescription ORAL AB Aug 21, 2019
EQ 75MG BASE tablet Prescription ORAL AB May 1, 2020
EQ 100MG BASE tablet Prescription ORAL AB May 1, 2020
EQ 50MG BASE tablet Prescription ORAL AB May 1, 2020


13. IMPAX LABS

Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Prescription ORAL AB Mar 23, 1999
EQ 100MG BASE capsule Prescription ORAL AB Mar 23, 1999
EQ 75MG BASE capsule Prescription ORAL AB Apr 18, 2001


14. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE capsule Prescription ORAL AB May 13, 2013
EQ 50MG BASE capsule Prescription ORAL AB May 13, 2013
EQ 100MG BASE capsule Prescription ORAL AB May 13, 2013


15. SANDOZ

Sandoz Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 90MG BASE tablet, extended release Prescription ORAL AB Aug 13, 2009
EQ 135MG BASE

(reference standard)

tablet, extended release Prescription ORAL AB Aug 13, 2009
EQ 45MG BASE tablet, extended release Prescription ORAL AB Aug 13, 2009


16. MEDICIS

Medicis Pharmaceutical Corp has filed for 1 generic for Minocycline Hydrochloride. This eq 50mg base version comes by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Medicis.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A Aug 14, 1990


17. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB Dec 30, 1991
EQ 75MG BASE capsule Prescription ORAL AB Jun 10, 1999


18. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG BASE tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 80MG BASE tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 90MG BASE tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 105MG BASE tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 135MG BASE tablet, extended release Discontinued ORAL N/A Nov 16, 2017
EQ 65MG BASE tablet, extended release Discontinued ORAL N/A Jun 16, 2023
EQ 115MG BASE tablet, extended release Discontinued ORAL N/A Jun 16, 2023
EQ 55MG BASE tablet, extended release Discontinued ORAL N/A Jun 16, 2023


19. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet Prescription ORAL AB Apr 16, 2003
EQ 50MG BASE tablet Prescription ORAL AB Apr 16, 2003
EQ 100MG BASE

(reference standard)

tablet Prescription ORAL AB Apr 16, 2003


20. SIDMAK LABS INDIA

Sidmak Laboratories India Pvt Ltd has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sidmak Labs India.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG BASE tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 80MG BASE tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 105MG BASE tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 45MG BASE tablet, extended release Prescription ORAL AB Dec 30, 2015
EQ 65MG BASE tablet, extended release Prescription ORAL AB Oct 7, 2022
EQ 55MG BASE tablet, extended release Prescription ORAL AB Oct 7, 2022
EQ 115MG BASE tablet, extended release Prescription ORAL AB Oct 7, 2022


21. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 135MG BASE tablet, extended release Prescription ORAL AB Nov 30, 2011
EQ 55MG BASE tablet, extended release Prescription ORAL AB Nov 30, 2011
EQ 45MG BASE tablet, extended release Prescription ORAL AB Nov 30, 2011
EQ 90MG BASE tablet, extended release Prescription ORAL AB Nov 30, 2011


22. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet Prescription ORAL AB Jan 29, 2016
EQ 50MG BASE tablet Prescription ORAL AB Jan 29, 2016
EQ 100MG BASE tablet Prescription ORAL AB Jan 29, 2016


23. TORRENT

Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE tablet Prescription ORAL AB Jan 6, 2004
EQ 100MG BASE tablet Prescription ORAL AB Jan 6, 2004
EQ 75MG BASE tablet Prescription ORAL AB Jan 6, 2004


24. ZYDUS

Zydus Worldwide Dmcc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

(reference standard)

capsule Prescription ORAL AB Mar 2, 1992
EQ 50MG BASE capsule Prescription ORAL AB Mar 2, 1992
EQ 75MG BASE capsule Prescription ORAL AB Aug 12, 2003


25. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE capsule Prescription ORAL AB Mar 11, 2008
EQ 100MG BASE capsule Prescription ORAL AB Mar 11, 2008
EQ 50MG BASE capsule Prescription ORAL AB Mar 11, 2008


26. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 80MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 45MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 105MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 135MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 90MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2016
EQ 65MG BASE tablet, extended release Prescription ORAL AB Mar 16, 2018
EQ 115MG BASE tablet, extended release Prescription ORAL AB Mar 16, 2018
EQ 55MG BASE tablet, extended release Prescription ORAL AB Dec 19, 2019